90 related articles for article (PubMed ID: 8237754)
1. Evidence for a reexcitability gap in man after treatment with type I antiarrhythmic drugs.
Haberman RJ; Rials SJ; Stohler JL; Marinchak RA; Kowey PR
Am Heart J; 1993 Nov; 126(5):1121-6. PubMed ID: 8237754
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
3. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
4. Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ.
Franz MR; Costard A
Circulation; 1988 May; 77(5):1177-84. PubMed ID: 3359594
[TBL] [Abstract][Full Text] [Related]
5. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
6. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.
Costard-Jaeckle A; Liem LB; Franz MR
J Cardiovasc Pharmacol; 1989 Dec; 14(6):810-7. PubMed ID: 2481766
[TBL] [Abstract][Full Text] [Related]
7. Relation between repolarization and refractoriness in the human ventricle: cycle length dependence and effect of procainamide.
Lee RJ; Liem LB; Cohen TJ; Franz MR
J Am Coll Cardiol; 1992 Mar; 19(3):614-8. PubMed ID: 1538018
[TBL] [Abstract][Full Text] [Related]
8. Quinidine elicits proarrhythmic changes in ventricular repolarization and refractoriness in guinea-pig.
Osadchii OE
Can J Physiol Pharmacol; 2013 Apr; 91(4):306-15. PubMed ID: 23627842
[TBL] [Abstract][Full Text] [Related]
9. Effect of procainamide on the postrepolarization refractoriness in cardiac muscle: evaluation using the block coupling interval in the artificial isthmus model in the canine right atrium.
Yoshizawa N; Niwano S; Moriguchi M; Kitano Y; Inuo K; Saito J; Izumi T
Pacing Clin Electrophysiol; 2001 Jul; 24(7):1100-7. PubMed ID: 11475826
[TBL] [Abstract][Full Text] [Related]
10. The effect of rate on prolongation of ventricular refractoriness by quinidine in humans.
Rosenheck S; Sousa J; Calkins H; Kadish AH; Morady F
Pacing Clin Electrophysiol; 1990 Nov; 13(11 Pt 1):1379-84. PubMed ID: 1701891
[TBL] [Abstract][Full Text] [Related]
11. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
Costard-Jäckle A; Franz MR
J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
[TBL] [Abstract][Full Text] [Related]
12. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
Kirchhof PF; Fabritz CL; Franz MR
Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478
[TBL] [Abstract][Full Text] [Related]
13. Effect of pentisomide (CM 7857) on myocardial excitation, conduction, repolarization, and refractoriness. An electrophysiological study in humans.
Olsson SB; Edvardsson N; Newell PA; Yuan S; Zeng Z
J Cardiovasc Pharmacol; 1991 Dec; 18(6):849-54. PubMed ID: 1725897
[TBL] [Abstract][Full Text] [Related]
14. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
[TBL] [Abstract][Full Text] [Related]
15. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
16. Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease.
Platia EV; Weisfeldt ML; Franz MR
Am J Cardiol; 1988 Jun; 61(15):1284-7. PubMed ID: 3376887
[TBL] [Abstract][Full Text] [Related]
17. The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate.
Rosenheck S; Schmaltz S; Kadish AH; Summitt J; Morady F
Am Heart J; 1991 Feb; 121(2 Pt 1):512-7. PubMed ID: 1990756
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
Feld GK; Venkatesh N; Singh BN
Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
[TBL] [Abstract][Full Text] [Related]
19. Effects of thoracic epidural anesthesia with and without autonomic nervous system blockade on cardiac monophasic action potentials and effective refractoriness in awake dogs.
Meissner A; Eckardt L; Kirchhof P; Weber T; Rolf N; Breithardt G; Van Aken H; Haverkamp W
Anesthesiology; 2001 Jul; 95(1):132-8; discussion 6A. PubMed ID: 11465550
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction.
Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW
Am Heart J; 1989 Oct; 118(4):702-8. PubMed ID: 2801477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
